Hippocampal Synaptic Dysfunction in a Mouse Model of Huntington Disease Is Not Alleviated by Ceftriaxone Treatment.

eNeuro · 2020 · PMC7242817 · PMID 32354757

Europe PMC DOI

hedged sentence

0.6600

closest p · 13.2× alpha

0.6600

boldest claim

The sentences

did not reach statistical significancep = 0.660not close (p > 0.1)

iGluSnFR response peaks were not different between the two genotypes, and while responses tended to be larger in ceftriaxone-treated mice, this did not reach statistical significance ( Fig. 2 E ; two-way ANOVA; genotype, p = 0.660; treatment, p = 0.064; interaction, p = 0.748).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.